- Home
- PTGX vs PEGA Comparison
PTGX vs PEGA Comparison
Compare PTGX & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | PEGA |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.3B |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PTGX | PEGA |
|---|---|---|
| Price | $97.01 | $34.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $108.23 | $60.13 |
| AVG Volume (30 Days) | 462.9K | ★ 1.6M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | N/A | ★ 91.89 |
| EPS | 0.05 | ★ 0.18 |
| Revenue | N/A | ★ $682,695,000.00 |
| Revenue This Year | $874.25 | $15.99 |
| Revenue Next Year | N/A | $11.90 |
| P/E Ratio | $2,055.80 | ★ $196.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.86 | $32.00 |
| 52 Week High | $107.84 | $102.79 |
Technical Indicators
Market Signals| Indicator | PTGX | PEGA |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 45.51 |
| Support Level | $96.36 | $32.00 |
| Resistance Level | $104.85 | $35.49 |
| Average True Range (ATR) | 4.25 | 1.65 |
| MACD | -0.26 | 0.35 |
| Stochastic Oscillator | 42.59 | 45.77 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.